Cargando…

Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel

Tyrosine kinase inhibitors (TKIs) have dramatically changed the survival of chronic myeloid leukemia (CML) patients, and treatment-free remission (TFR) has recently emerged as a new goal of CML treatment. The aim of this work was to develop recommendations for TKI discontinuation in Latin America (L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pavlovsky, Carolina, Abello Polo, Virginia, Pagnano, Katia, Varela, Ana Ines, Agudelo, Claudia, Bianchini, Michele, Boquimpani, Carla, Centrone, Renato, Conchon, Monica, Delgado, Nancy, Funke, Vaneuza, Giere, Isabel, Luise, Ingrid, Meillon, Luis, Moiraghi, Beatriz, Navarro, Juan Ramon, Pilleux, Lilian, Prado, Ana Ines, Undurraga, Soledad, Cortes, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2021
Materias:	Clinical Trials and Observations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153024/ https://www.ncbi.nlm.nih.gov/pubmed/34438444 http://dx.doi.org/10.1182/bloodadvances.2020003235

Ejemplares similares

Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice
por: Boquimpani, Carla, et al.
Publicado: (2022)

Chronic myeloid leukemia treatment guidelines: Brazilian Association of Hematology, Hemotherapy and Cell Therapy. Brazilian Medical Association Guidelines Project - 2012
por: de Souza, Carmino Antonio, et al.
Publicado: (2012)

Planned Pregnancy in a Chronic Myeloid Leukemia Patient in Molecular Remission
por: Pavlovsky, Carolina, et al.
Publicado: (2012)

Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal
por: Pavlovsky, Carolina, et al.
Publicado: (2023)

COVID-19 in Chronic Myeloid Leukemia Patients - Brazilian Experience
por: Pagnano, Katia B, et al.
Publicado: (2020)

Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring
por: Seguro, Fernanda Salles, et al.
Publicado: (2021)

Guideline on myeloproliferative neoplasms: Associacão Brasileira de Hematologia, Hemoterapia e Terapia Cellular: Project guidelines: Associação Médica Brasileira – 2019
por: Tavares, Renato Sampaio, et al.
Publicado: (2019)

COVID-19 IN CHRONIC MYELOID LEUKEMIA PATIENTS – BRAZILIAN EXPERIENCE
por: Pagnano, KBB, et al.
Publicado: (2021)

In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy
por: Sanchez, María Belén, et al.
Publicado: (2023)

Prevalence of Anaemia and Evaluation of Transferrin Receptor (sTfR) in the Diagnosis of Iron Deficiency in the Hospitalized Elderly Patients: Anaemia Clinical Studies in Chile
por: López-Sierra, Mauricio, et al.
Publicado: (2012)

Molecular response to imatinib mesylate of Brazilian patients with chronic myeloid leukemia
por: Vieira-Mion, Ana Lucia, et al.
Publicado: (2017)

COVID-19 IN CHRONIC MYELOID LEUKEMIA PATIENTS – BRAZILIAN EXPERIENCE
por: Pagnano, K.B.B., et al.
Publicado: (2020)

Prolonged remission in latent autoimmune diabetes of adults (LADA): Is insulin resistance a major influence?
por: Rocha, José Vicente, et al.
Publicado: (2023)

Mutations in the breakpoint cluster region-Abelson murine leukemia 1 gene in Brazilian patients with chronic myeloid leukemia
por: Costa, Heloísa Zorzi, et al.
Publicado: (2018)

P662: POST HOC ANALYSIS OF PATIENT RESPONSES BY T315I MUTATION STATUS FROM THE 3-YEAR UPDATE OF THE OPTIC TRIAL: A DOSE-OPTIMIZATION STUDY OF 3 STARTING DOSES OF PONATINIB
por: Cortes, Jorge, et al.
Publicado: (2023)

Dasatinib - clinical trials and management of adverse events in imatinib resistant/intolerant chronic myeloid leukemia
por: Conchon, Monika, et al.
Publicado: (2011)

miRNome profiling of LSC-enriched CD34(+)CD38(−)CD26(+) fraction in Ph(+) CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool
por: Ruiz, María Sol, et al.
Publicado: (2021)

Pre-sarcopenia and bone mineral density in adults submitted to hematopoietic stem cell transplantation
por: Pereira, Cristiane Pavan, et al.
Publicado: (2017)

Tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia: defining the role of social risk factors and non-adherence to treatment
por: Okumura, Lucas M., et al.
Publicado: (2015)

Oral cancer after prolonged immunosuppression for multiorgan chronic graft-versus-host disease
por: de Araújo, Renata Lins Fuentes, et al.
Publicado: (2014)

Unrelated hematopoietic stem cell transplantation in the pediatric population: single institution experience
por: Marinho, Daniela Hespanha, et al.
Publicado: (2015)

Remission in Depression and Associated Factors at Different Assessment Times in Primary Care in Chile
por: Vitriol, Veronica, et al.
Publicado: (2018)

Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome
por: Valencia, Marcelo, et al.
Publicado: (2015)

GVHD treatment with extracorporeal photopheresis in Brazil: a national survey
por: Fatobene, Giancarlo, et al.
Publicado: (2022)

Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission
por: Serpa, Mariana, et al.
Publicado: (2010)

Accelerated phase chronic myeloid leukemia: evaluation of clinical criteria as predictors of survival, major cytogenetic response and progression to blast phase
por: Furtado, Vanessa Fiorini, et al.
Publicado: (2015)

Furosemide-induced pseudoporphyria in a patient with chronic kidney disease: case report
por: Pavanelli, Giovana Memari, et al.
Publicado: (2018)

Evaluation of the primitive fraction by functional in vitro assays at the RNA and DNA level represents a novel tool for complementing molecular monitoring in chronic myeloid leukemia
por: Ruiz, María Sol, et al.
Publicado: (2018)

La explicación de la ciencia : un acercamiento cognoscitivo
por: Giere, Ronald N.
Publicado: (1992)

Explaining science: a cognitive approach
por: Giere, Ronald N
Publicado: (1988)

Vitamin D deficiency in children and adolescents submitted to hematopoietic stem cell transplantation
por: Campos, Denise Johnsson, et al.
Publicado: (2014)

Evolution of myelodisplasic syndrome with ring sideroblasts (MDS-RS) to systemic mastocytosis and aleukemic mast cell leukemia
por: Costa, Larissa da, et al.
Publicado: (2020)

Rheumatoid Arthritis: Defining Clinical and Ultrasound Deep Remission
por: Hèctor, Corominas, et al.
Publicado: (2020)

Remission of aHUS neurological damage with eculizumab
por: Ávila, Ana, et al.
Publicado: (2015)

Bilateral acute macular neuroretinopathy in a young woman after the first dose of Oxford–AstraZeneca COVID-19 vaccine
por: Gabrielle, Pierre-Henry, et al.
Publicado: (2022)

Time to achieve remission determines time to be in remission
por: Schipper, Lydia G, et al.
Publicado: (2010)

Peripapillary Microvascularization Analysis Using Swept-Source Optical Coherence Tomography Angiography in Optic Chiasmal Compression
por: Ben Ghezala, Inès, et al.
Publicado: (2021)

Investigation of MHC gamma block C4A and C4B polymorphisms in unrelated hematopoietic stem cell transplantation
por: Getz, Joselito, et al.
Publicado: (2020)

Infliximab for medical induction of remission in Crohn's disease
por: Gordon, Morris, et al.
Publicado: (2023)

Ultrasound remission in patients with rheumatoid arthritis in clinical remission
por: Fakhfakh, Rym, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qr7rbmqchaiogc4jh66opdu8k0